Boletin 50 - Primer cuatrimestre 2018

 

Boletín Primer Cuatrimestre 2018

Noticias

Artículos de opinión

Programas de rehabilitación online en la esquizofrenia: ¿apocalipticos o integrados?

Alejandro García Caballero

Hospital de Día de Psiquiatría, Complexo Hospitalario Universitario de Ourense, Instituto Biomédico
Galicia Sur, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM).
Departamento de Psiquiatría, Facultad de Medicina, Universidad de Santiago de Compostela.

Resumen de Evidencia

Trastorno límite de la personalidad


Matilde Blanco Venzalá, Raquel Remesal Cobreros, María Felipa Soriano Alonso y
Ángel Luis Mena Jiménez
 
 

CAT 's

Nuevas Evidencias

  • Skovlund CW, Morch LS, Kessing LV, y col. Asociación de Anticoncepción Hormonal con Intentos de Suicidio y Suicidios. Am J Psiquiatría. 2017 17 de noviembre: appiajp201717060616. doi: 10.1176 / appi.ajp.2017.17060616. (Original) PMID: 29145752
  • El-Sayeh HG, Rathbone J, Soares-Weiser K, et al. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018 Jan 18;1:CD000458. doi: 10.1002/14651858.CD000458.pub3. (Review) PMID: 29342497
  • Kemper AR, Maslow GR, Hill S, et al. Attention deficit hyperactivity disorder: diagnosis and treatment in children and adolescents. Comparative Effectiveness Review No. 203. AHRQ Publication No. 18-EHC005-EF. Rockville, MD: Agency for Healthcare Research and Quality; January 2018. (Review)
  • Foa EB, McLean CP, Zang Y, et al. Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial. JAMA. 2018 Jan 23;319(4):354-364. doi: 10.1001/jama.2017.21242. (Original) PMID: 29362795
  • Matthews PRL, Horder J, Pearce M. Selective noradrenaline reuptake inhibitors for schizophrenia. Cochrane Database Syst Rev. 2018 Jan 25;1:CD010219. doi: 10.1002/14651858.CD010219.pub2. (Review) PMID: 29368813
  • Soares-Weiser K, Maayan N, Bergman H. Vitamin E for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018 Jan 17;1:CD000209. doi: 10.1002/14651858.CD000209.pub3. (Review) PMID: 29341067
  • Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Am J Psychiatry. 2017 Dec 5:appiajp201717060647. doi: 10.1176/appi.ajp.2017.17060647. (Original) PMID: 29202655
  • Sampaio-Junior B, Tortella G, Borrione L, et al. Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2018 Feb 1;75(2):158-166. doi: 10.1001/jamapsychiatry.2017.4040. (Original) PMID: 29282470
  • Bergman H, Rathbone J, Agarwal V, et al. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia. Cochrane Database Syst Rev. 2018 Feb 6;2:CD000459. doi: 10.1002/14651858.CD000459.pub3. (Review) PMID: 29409162
  • Soares-Weiser K, Rathbone J, Ogawa Y, et al. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018 Mar 19;3:CD000208. doi: 10.1002/14651858.CD000208.pub2. (Review) PMID: 29552749
  • Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Feb 20. pii: S0140-6736(17)32802-7. doi: 10.1016/S0140-6736(17)32802-7. (Review) PMID: 29477251
  • Lopez PL, Torrente FM, Ciapponi A, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2018 Mar 23;3:CD010840. doi: 10.1002/14651858.CD010840.pub2. (Review) PMID: 29566425